Filing Details
- Accession Number:
- 0001237899-21-000011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-10 17:00:34
- Reporting Period:
- 2021-08-06
- Accepted Time:
- 2021-08-10 17:00:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1225471 | L George Sing | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-08-06 | 3,000 | $611.43 | 51,663 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-08-06 | 1,000 | $611.23 | 50,663 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-08-10 | 600 | $615.00 | 50,063 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-08-10 | 1,000 | $614.00 | 49,063 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-08-10 | 1,000 | $613.01 | 48,063 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-08-06 | 350 | $612.42 | 3,350 | No | 4 | S | Indirect | by Trust for Son |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Indirect | by Trust for Son |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,150 | Indirect | by Spouse |
Common Stock | 400 | Indirect | by Spouse/Cust Son |
Footnotes
- Represents volume-weighted average price of sales of 1,000 shares of Company stock on August 10, 2021 at prices ranging from $613.00 to $613.05. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price.